Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 3, 2015, Pages 460-467

  Seiffert, Moritz ^a   Conradi, Lenard ^a   Terstesse, Ann Christine ^a   Koschyk, Dietmar ^a   Schirmer, Johannes ^a   Schnabel, Renate B ^a   Wilde, Sandra ^a   Ojeda, Francisco M ^a   Reichenspurner, Hermann ^a   Blankenberg, Stefan ^a   Schäfer, Ulrich ^a   Treede, Hendrik ^a   Diemert, Patrick ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Structural heart disease intervention; Surgery; Transcatheter valve implantation; Valvular

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULANT THERAPY; AORTA PROSTHESIS; AORTA VALVE DISEASE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BODY MASS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ADVERSE EFFECTS; AORTA VALVE; GERMANY; HEART CATHETERIZATION; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; HEMORRHAGE; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PROCEDURES; RISK ASSESSMENT; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; BLOOD TRANSFUSION; CARDIAC CATHETERIZATION; FEMALE; GERMANY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923032443     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25691     Document Type: Article

References (27)

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, Bonis M De, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers H-J, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Oppell UO Von, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
2. Kappetein a P, Head SJ, Généreux P, Piazza N, Mieghem NM van, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, Es G-A van, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-1454.
3. Généreux P, Head SJ, Mieghem NM Van, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-2326.
4. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, Carlo M De, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
5. Seiffert M, Schnabel R, Conradi L, Diemert P, Schirmer J, Koschyk D, Linder M, Kersten JF, Grosser A, Wilde S, Blankenberg S, Reichenspurner H, Baldus S, Treede H. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2013;82:640-652.
6. Halliday BP, Dworakowski R, Brickham B, Wendler O, MacCarthy P. Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation. Am J Cardiol 2012;109:724-728.
7. Rao S V, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-1562.
8. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: A meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 2013;173:132-139.
9. Doyle BJ, Rihal CS, Gastineau Da, Holmes DR. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: Implications for contemporary practice. J Am Coll Cardiol 2009;53:2019-2027.
10. Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA 2014; 311:836-843.
11. Murphy GJ, Reeves BC, Rogers Ca, Rizvi SIa, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552.
12. World Health Organization. 2001. Iron deficiency anaemia: Aassessment, prevention and control. Available at: http:// www.who.int/nutrition/publications/micronutrients/anaemia_iron_ deficiency/WHO_NHD_01.3/en/. Accessed 03 March 2014.
13. Tchetche D, Boon RMA Van der, Dumonteil N, Chieffo A, Mieghem NM Van, Farah B, Buchanan GL, Saady R, Marcheix B, Serruys PW, Colombo A, Carrie D, Jaegere PPT De, Fajadet J. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: Insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. Am Heart J 2012;164:402-409.
14. Nuis R-J, Rodés-Cabau J, Sinning J-M, Garsse L van, Kefer J, Bosmans J, Dager AE, Mieghem N van, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Dumont E, Domburg RT van, Jaegere PP de. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012;5:680-688.
15. Binder RK, Barbanti M, Ye J, Toggweiler S, Tan J, Freeman M, Cheung A, Wood DA, Webb JG. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: Recommendations for patients who refuse blood transfusion. Catheter Cardiovasc Interv 2014;83:E221-E226.
16. Nuis R-J, Sinning J-M, Rodés-Cabau J, Gotzmann M, Garsse L van, Kefer J, Bosmans J, Yong G, Dager AE, Revilla-Orodea A, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Amat-Santos IJ, López J, Dumont E, Mieghem N van, Gelder T van, Domburg RT van, Jaegere PP de. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013;6:625-634.
17. Mieghem NM Van, Nuis R-J, Tzikas A, Piazza N, Schultz C, Serruys PW, Jaegere PP de. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2011;7:184-191.
18. Elmistekawy E, Rubens F, Hudson C, McDonald B, Ruel M, Lam K, Mesana TG, Boodhwani M. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardio-Thoracic Surg 2013;44:1051-1055; discussion 1055-6.
19. Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao S V, Gibler WB, Ohman EM, Peterson ED. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005;46:1490-1495.
20. Nikolsky E, Mehran R, Sadeghi HM, Grines CL, Cox Da, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Stone GW. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: Analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. JACC Cardiovasc Interv 2009;2:624-632.
21. Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR, Al-Khalidi HR, Patel MR, Werf FJ Van de, Pieper K, Armstrong PW, Granger CB. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J 2009;30:2575-2583.
22. Paone G, Likosky DS, Brewer R, Theurer PF, Bell GF, Cogan CM, Prager RL. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg 2014;97:87-94.
23. Kilic A, Whitman GJR. Blood transfusions in cardiac surgery: Indications, risks, and conservation strategies. Ann Thorac Surg 2014;97:726-734.
24. Hajjar LA, Vincent J-L, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NAG, Auler JOC. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010;304: 1559-1567.
25. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
26. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-1236.
27. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet 2013;381:1845-1854.